|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q90579449
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241120235953.0 |
|
008
|
|
|
241120nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q90579449
|
|
024
|
|
|
‡a
0000-0002-9334-9046
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q90579449
|
|
100
|
0 |
|
‡a
Rebecca E Chandler
‡c
researcher (ORCID 0000-0002-9334-9046)
‡9
en
|
|
400
|
0 |
|
‡a
Rebecca E Chandler
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Increased risk for aseptic meningitis after amoxicillin or amoxicillin-clavulanic acid in males: A signal revealed by subset disproportionality analysis within a global database of suspected adverse drug reactions
|
|
670
|
|
|
‡a
Author's Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real-world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from large health-care databases
|
|
670
|
|
|
‡a
Author's Optimizing safety surveillance for COVID-19 vaccines
|
|
670
|
|
|
‡a
Author's Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase
|
|
670
|
|
|
‡a
Author's Suspicions of possible vaccine harms must be scrutinised openly and independently to ensure confidence
|
|
670
|
|
|
‡a
Author's The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic
|
|
909
|
|
|
‡a
(orcid) 0000000293349046
‡9
1
|
|
919
|
|
|
‡a
optimizingsafetysurveillanceforcovid19vaccines
‡A
Optimizing safety surveillance for COVID-19 vaccines
‡9
1
|
|
919
|
|
|
‡a
riskfactorconsiderationsinstatisticalsignaldetectionusingsubgroupdisproportionalitytouncoverriskgroupsforadversedrugreactionsinvigibase
‡A
Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase
‡9
1
|
|
919
|
|
|
‡a
increasedriskforasepticmeningitisafteramoxicillinoramoxicillinclavulanicacidinmalesasignalrevealedbysubsetdisproportionalityanalysiswithinaglobaldatabaseofsuspectedadversedrugreactions
‡A
Increased risk for aseptic meningitis after amoxicillin or amoxicillin-clavulanic acid in males: A signal revealed by subset disproportionality analysis within a global database of suspected adverse drug reactions
‡9
1
|
|
919
|
|
|
‡a
suspicionsofpossiblevaccineharmsmustbescrutinisedopenlyandindependentlytoensureconfidence
‡A
Suspicions of possible vaccine harms must be scrutinised openly and independently to ensure confidence
‡9
1
|
|
919
|
|
|
‡a
roleofpharmacovigilanceandisopduringtheglobalcovid19pandemic
‡A
The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic
‡9
1
|
|
919
|
|
|
‡a
nintedanibandischemiccolitissignalassessmentwiththeintegrateduseof2typesofrealworldevidencespontaneousreportsofsuspectedadversedrugreactionsandobservationaldatafromlargehealthcaredatabases
‡A
Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real-world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from large health-care databases
‡9
1
|
|
996
|
|
|
‡2
J9U|987007371188605171
|
|
996
|
|
|
‡2
JPG|500183851
|
|
996
|
|
|
‡2
LC|n 90690075
|
|
996
|
|
|
‡2
CAOONL|ncf10038038
|
|
996
|
|
|
‡2
J9U|987007345149105171
|
|
996
|
|
|
‡2
LC|no2016010550
|
|
996
|
|
|
‡2
CAOONL|ncf10025500
|
|
996
|
|
|
‡2
BIBSYS|12048365
|
|
996
|
|
|
‡2
SUDOC|254678483
|
|
996
|
|
|
‡2
LC|no2009192606
|
|
996
|
|
|
‡2
ISNI|0000000032389824
|
|
996
|
|
|
‡2
LC|no2018040580
|
|
996
|
|
|
‡2
NTA|072603216
|
|
996
|
|
|
‡2
LC|n 50036285
|
|
996
|
|
|
‡2
ISNI|0000000073419567
|
|
996
|
|
|
‡2
LC|no 00099865
|
|
996
|
|
|
‡2
ISNI|0000000356237958
|
|
996
|
|
|
‡2
ISNI|0000000033361217
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
